vimarsana.com

Latest Breaking News On - Dose escalation clinical trials - Page 1 : vimarsana.com

AGTC to Showcase Interim Findings from Ongoing XLRP and

GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical.

United statesUnited kingdomJonathan lieberRachel huckfeldtPaul yangKerry sinclairSusan schneiderAlessandro iannacconeGenetic technologies corporationProfessor of ophthalmology at harvard medical schoolSpectrum science communicationsOtonomy incCasey eye instituteOregon health science university in portlandAssociation for researchChief medical officer

AGTC to Showcase Interim Findings from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting

04.04.2022 - GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) - Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based gene . Seite 1

United statesUnited kingdomRachel huckfeldtSusan schneiderAlessandro iannacconeGenetic technologies corporationProfessor of ophthalmology at harvard medical schoolAssociation for researchChief medical officerVisual photosensitivityTwo phaseSubretinal gene therapyAssistant professorHarvard medicalFour seasons ballroomSafety results

vimarsana © 2020. All Rights Reserved.